Software provides view into biological mechanisms.
Press Release Summary:
As Web-based application, Ingenuity Pathways Analysis (IPA) v3.1 enables biologists and bioinformaticians to optimize workflow to understand biological mechanisms, pathways, and functions. It integrates with third party and customer applications through dedicated APIs and supports Affymetrix GeneChip Human Mapping 10K, 100K, and 500K Array Sets. Application leverages expert curated Ingenuity content, containing 1.4 million biological findings.
Original Press Release:
Ingenuity Systems Launches New Product IPA 3.1, Delivering Expanded Functionality and Performance
REDWOOD CITY, Calif., Jan. 31 /-- Ingenuity Systems today announced the launch of Ingenuity Pathways Analysis (IPA) 3.1, a web-based software application that enables biologists and bioinformaticians to understand biological mechanisms, pathways and functions. The new release of IPA 3.1 seamlessly integrates with 3rd party and customer applications through dedicated APIs and supports Affymetrix GeneChip Human Mapping 10K, 100K and 500K Array Sets, thus greatly expanding the relevance of IPA to biomarker and pharmacogenomic research efforts.
"IPA 3.1 meets the need in the marketplace for a robust pathways product that can be effortlessly integrated with proprietary and third party applications," said Ramon Felciano, Ph.D. Chief Technology Officer and Vice President, Research for Ingenuity. "With the addition of new APIs, our customers now have the flexibility to incorporate IPA into their internal tools and thus optimize the workflow for understanding the biological mechanisms, pathways and functions most relevant to their research."
"By integrating the Affymetrix Mapping 10k, 100k and 500k products with Ingenuity Pathways Analysis, we are enabling researchers to comprehensively investigate SNP information in the context of the biological mechanisms of a particular disease," stated Greg Yap, Vice President of DNA Products, at Affymetrix. "Researchers can use this technology to analyze their expression and genotyping experiments together in a single unified pathways view of the underlying biology."
Highlights of the Ingenuity Pathways Analysis 3.1 release include:
-- Application Programming Interfaces (APIs): Facilitate integration with your application and IPA for optimized workflow.
-- Mapping Files for SNPs: Map Affymetrix SNP identifiers. Mapping files now support Affymetrix GeneChip Human Mapping 10K, 100K and 500K Array Sets.
-- Updated Content: Leverage the newly acquired, high quality expert curated Ingenuity content containing 1.4 million biological findings.
Trials of Ingenuity Pathways Analysis 3.1 are being offered at www.ingenuity.com/trial . For more information about Ingenuity Pathways Analysis 3.1, please email sales@ingenuity.com or go to www.ingenuity.com.
About Ingenuity Systems(R)
Ingenuity enables researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan. www.ingenuity.com.
CONTACT: Heidi Bullock, Director, Marketing of Ingenuity, +1-650-381-5150
